This disclosure generally relates to, among other things, implantable ventricular assist devices; particularly to modular implantable ventricular assist devices that can be, at least in part, assembled within a patient.
Ventricular assist devices (VADs) are mechanical pumps that take over the function of a damaged ventricle in a heart failure (HF) or other appropriate patient in order to reestablish normal hemodynamics and end-organ blood flow. In addition, VADs unload the native heart allowing it to rest and, in some cases, the heart can recover function. They can be used as short-term support (days) or as long-term support (weeks or months). VADs can support the right, left or both ventricles. In a left VAD (LVAD) an inflow cannula is connected to the apex of the left ventricle and an outflow cannula is connected to the ascending aorta, whereas in a right VAD (RVAD), the inflow cannula is connected to either right atrium or ventricle and the outflow cannula is connected to the pulmonary artery. The pump can be placed outside the patient's body (extra- or para-corporeal devices) or within the abdomen in a preperitoneal position immediately under the diaphragm or above the diaphragm in the pericardial space (intracorporeal devices).
First generation VADs include pulsatile volume displacement pumps and two valves (outflow and inflow valves). The pumps are driven by either pneumatic or electrical drive systems. Examples of these devices are the commercially available Thoratec PVAD, IVAD, and HeartMate XVE, and the no longer commercially available Thoratec HeartMate IP1000 and VE, the WorldHeart Novacor and the Arrow International LionHeart LVD2000.
Second generation VADs include implantable, continuous flow, rotary pumps with axial flow that offer several advantages over the first-generation devices. Some of the advantages are the smaller size that reduces the risk of infections and simpler implantation. There are fewer moving parts, absence of valves to direct blood flow, smaller blood-contacting surfaces and reduced energy requirements that enhance simplicity and durability. These pumps have an internal rotor within the blood flow path that is suspended by contact bearings, which imparts tangential velocity and kinetic energy to the blood. The net action results in generation of a net pressure rise across the pump. An external system driver connected by a percutaneous lead powers the pump. Some of the greatest limitations of this type of device are hemolysis, ventricular suction, thrombus formation and pump stoppage. Examples of these devices are the commercially available Thoratec HeartMate II, the Jarvik Heart Jarvik 2000 and the MicroMed Heart Assist 5.
Third-generation VADs include centrifugal continuous-flow pumps with an impeller or rotor suspended in the blood flow path using a noncontact bearing design, which uses either magnetic or hydrodynamic levitation. The levitation systems suspend the moving impeller within the blood field without any mechanical contact, thus eliminating frictional wear and reducing heat generation. This feature promises longer durability and higher reliability with low incidence of device failure and need for replacement. Usually, magnetic levitation devices are larger owing to the need for complex position sensing and control system that increases requirements for a large pump size. Examples of these devices are the commercially available Terumo DuraHeart and the HeartWare HVAD, the in development Sun Medical Technology EVAHEART LVAS and the no longer commercially available Ventracor VentrAssist.
All of the VADs discussed above include a pump external to the patient's vasculature and tubing from the pump to a chamber of the patient's heart, aorta or pulmonary artery. In any case, implantation procedures for such VADs are typically invasive.
This disclosure describes, among other things, VADs that are implantable in a minimally invasive manner and methods for implanting such VADs. In embodiments, the VADs are contained entirely within a patient's cardiovascular system. In embodiments, the VADs are implanted transvascularly, which can be similar to a manner of transcatheter aortic valve implantation.
In embodiments described herein, a ventricular assist device includes a frame having an expanded configuration and a collapsed configuration. The frame, in the expanded configuration, is configured to engage tissue of a patient, such as an inner wall of a blood vessel, when implanted. The ventricular assist device further includes a pump assembly having one or more components configured to operably couple to the frame when the frame is implanted and in the expanded configuration.
In embodiments described herein, a method includes implanting a frame in a vessel of a patient. The frame has a structural scaffold configured to engage the vessel and a lumen defined therethrough. The method further includes operably coupling one or more components of a pump assembly to the frame after the frame is implanted in the vessel.
In embodiments described herein, a method includes deploying a frame in a vessel of a patient. The frame engages the vessel when deployed. The method further includes operably coupling one or more components of a pump assembly to the deployed frame, such that the pump assembly is configured to pump fluid through the frame along a longitudinal axis of the frame.
One or more embodiments of the apparatuses, systems or methods described herein provide one or more advantages over prior ventricular assist devices. For example the ventricular assist devices described in embodiments herein can be implanted in a minimally invasive manner via a transcatheter. The ventricular assist devices, in embodiments, are modular to allow several smaller, lower profile components to be assembled within the patient. By making the ventricular assist devices modular and having lower profile components, the components may be delivered via a transcatheter where fully assembled assemblies having larger profiles may not be amenable to transcatheter implantation. These and other advantages will be readily understood by those of skill in the art from the following detailed description.
The schematic drawings are not necessarily to scale. Like numbers used in the figures refer to like components, steps and the like. However, it will be understood that the use of a number to refer to a component in a given figure is not intended to limit the component in another figure labeled with the same number. In addition, the use of different numbers to refer to components is not intended to indicate that the different numbered components cannot be the same or similar.
In the following detailed description several specific embodiments of compounds, compositions, products and methods are disclosed. It is to be understood that other embodiments are contemplated and may be made without departing from the scope or spirit of the present disclosure. The following detailed description, therefore, is not to be taken in a limiting sense.
This disclosure generally relates to, among other things, VADs that are implantable in a minimally invasive manner and methods for implanting such VADs. In embodiments, the VADs are contained entirely within a patient's cardiovascular system. In embodiments, the VADs are implanted transvascularly, which can be similar to a manner of transcatheter aortic valve implantation.
In embodiments described herein, a ventricular assist pump device assembly includes a frame having an expanded configuration and a collapsed configuration having generally smaller diametric dimensions than the expanded configuration. In the expanded configuration, the frame is configured to engage tissue of a patient such that the frame is anchored relative to the tissue of the patient. The device assembly further includes a pump assembly having one or more components configured to operably couple to the frame when the frame is implanted and in the expanded configuration. Thus final assembly of the device assembly can occur within a patient.
In embodiments, the one or more components of the pump assembly are advanced through the patients vasculature to the frame or one or more components of the pump assembly a distance of greater than 50 cm, such as 100 cm or more, or 200 cm or more.
In embodiments, the frame, in a collapsed configuration, is delivered to a desired location of the patient via a catheter. Once properly positioned, the frame is expanded or allowed to expand to engage tissue of the patient. In embodiments, the one or more pump components are delivered via a catheter and are operably coupled to the expanded frame that is implanted in the patient.
In embodiments, the frame is configured to engage an inner wall of a vessel of the patient, such as a vein or an artery. In embodiments, the frame is configured to engage the aorta of a patient when the frame is in the expanded configuration.
The frame of a ventricular assist pump device assembly can be a frame of a replacement heart valve, such as a frame of a Medtronic COREVALVE replacement heart valve, or substantially similar to a frame of a replacement heart valve. In embodiments, an entire replacement heart valve (as opposed to just the frame) may be employed.
In embodiments, the frames include a series of wires or wire segments. In embodiments, the frames are formed from a single piece of material. For example, the frames may be laser-cut from a single piece of material.
The frames are configured such that they are capable of transitioning from a collapsed configuration to an expanded configuration. In the collapsed configuration, the frame has a smaller diametric dimension than in the expanded configuration. The frame may be compressed or retained in a compressed state to achieve the collapsed configuration. In embodiments, the frame can self-transition from a collapsed configuration to an expanded configuration. A sleeve or other retaining member may be used to retain the frame in the collapsed configuration. The retaining member may be withdrawn from about the frame when the frame is properly positioned to allow the frame to expand and engage tissue of the patient. In embodiments, the frame may be actively expanded from a collapsed configuration to an expanded configuration. For example, the frame may be expanded by a spring or other biasing mechanism, by a balloon, or the like.
In embodiments, the frame, or one or more portions thereof, is formed from shape memory material that is self-expandable from a collapsed configuration to an expandable configuration by the application of heat, energy, or the like, or by the removal of external forces (e.g., compressive forces applied by a retaining member). Any suitable shape memory material may be employed. One example of a suitable shape memory material is a nickel-titanium alloy, such as NITINOL.
Preferably, the frame can be collapsed and expanded multiple times without damaging the structure of the frame.
A frame of a ventricular assist device may be delivered to the patient in any suitable manner. In embodiments, the frame is delivered via a catheter; e.g., a transcatheter. Examples of suitable delivery systems for embodiments of frames disclosed herein (and suitable frames) are disclosed in U.S. 2011/0098805, now U.S. Pat. No. 8,414,645, issued Apr. 9, 2013, entitled TRANSCATHETER VALVE DELIVERY SYSTMS AND METHODS, which published patent application is hereby incorporated herein by reference in its entirety to the extent that it does not conflict with the present disclosure.
One or more pump assembly component may be coupled to the expanded frame that is implanted in the patient. The one or more pump assembly components, in various embodiments, can be delivered to the implanted frame for attachment to the frame via a catheter; e.g., a transcatheter.
The pump components may be coupled to the frame or to each other via any suitable features. In embodiments, the components are attached to the frame or each other via one way clips or retention features.
In embodiments, one or more of the pump assembly components are minipumps. Minipumps are self-contained pumps that typically pump low volumes of fluid, such as about 1 liter/minute. Accordingly, more than one minipump may be employed and coupled to the frame. For example, if a micropump pumps about 1 L/min, from about 5 to about 8 pumps may be desired to simulate cardiac output.
In embodiments, the pump assemblies are impeller-type pumps. In embodiments, the impeller includes a shaft and impellers that are coupled to the frame prior to implanting the frame. A housing or housing components may then be coupled to the shaft (and thus operably coupled to the frame) after the frame and shaft are implanted.
With the above understanding in mind, some specific embodiments of VADs, components of VADs, delivery systems and methods are described below.
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
It will be understood that the mechanism for coupling a pump or pump component to a frame depicted in, and described with regard to,
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
The pumps, pump components, frames and delivery systems depicted with regard to any one figure or embodiment may be used or modified for use with any other suitable embodiment depicted or described herein.
Definitions
All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein and are not meant to limit the scope of the present disclosure.
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” encompass embodiments having plural referents, unless the content clearly dictates otherwise.
As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. The term “and/or” means one or all of the listed elements or a combination of any two or more of the listed elements.
As used herein, “have”, “having”, “include”, “including”, “comprise”, “comprising” or the like are used in their open ended sense, and generally mean “including, but not limited to”. It will be understood that “consisting essentially of”, “consisting of”, and the like are subsumed in “comprising” and the like. As used herein, “consisting essentially of,” as it relates to a composition, product, method or the like, means that the components of the composition, product, method or the like are limited to the enumerated components and any other components that do not materially affect the basic and novel characteristic(s) of the composition, product, method or the like.
The words “preferred” and “preferably” refer to embodiments of the invention that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the disclosure, including the claims.
Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, etc. or 10 or less includes 10, 9.4, 7.6, 5, 4.3, 2.9, 1.62, 0.3, etc.). Where a range of values is “up to” a particular value, that value is included within the range.
Any direction referred to herein, such as “top,” “bottom,” “left,” “right,” “upper,” “lower,” and other directions and orientations are described herein for clarity in reference to the figures and are not to be limiting of an actual device or system or use of the device or system. Devices or systems as described herein may be used in a number of directions and orientations.
Thus, embodiments of MODULAR VENTRICULAR ASSIST DEVICE are disclosed. One skilled in the art will appreciate that the leads, devices such as signal generators, systems and methods described herein can be practiced with embodiments other than those disclosed. The disclosed embodiments are presented for purposes of illustration and not limitation. One will also understand that components of the leads depicted and described with regard the figures and embodiments herein may be interchangeable.
Number | Name | Date | Kind |
---|---|---|---|
6136025 | Barbut et al. | Oct 2000 | A |
7144364 | Barbut et al. | Dec 2006 | B2 |
7841976 | McBride et al. | Nov 2010 | B2 |
7942804 | Khaw | May 2011 | B2 |
8449443 | Rodefeld et al. | May 2013 | B2 |
20110004046 | Campbell et al. | Jan 2011 | A1 |
20110071338 | McBride et al. | Mar 2011 | A1 |
20110098805 | Dwork et al. | Apr 2011 | A1 |
20110257462 | Rodefeld et al. | Oct 2011 | A1 |
20120172654 | Bates | Jul 2012 | A1 |
20120172655 | Campbell et al. | Jul 2012 | A1 |
20120172656 | Walters et al. | Jul 2012 | A1 |
20120178986 | Campbell et al. | Jul 2012 | A1 |
20130066140 | McBride et al. | Mar 2013 | A1 |
Entry |
---|
Alba, et al. “The Future is Here: Ventricular Assist Devices for the Failing Heart” Expert Rev Cardiovasc Ther. 2009; 7(9): 1067-1077. |
Number | Date | Country | |
---|---|---|---|
20150250935 A1 | Sep 2015 | US |
Number | Date | Country | |
---|---|---|---|
61948236 | Mar 2014 | US |